1332P Effects of immune checkpoint inhibitors for EGFR-wild/ALK-negative NSCLC patients with untreated brain metastases.

Autor: Iuchi, T.1 (AUTHOR), Shingyoji, M.2 (AUTHOR), Ashinuma, H.2 (AUTHOR), Mizuno, S.2 (AUTHOR), Hasegawa, Y.1 (AUTHOR), Setoguchi, T.1 (AUTHOR), Hosono, J.1 (AUTHOR), Sakaida, T.1 (AUTHOR)
Zdroj: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS845-S846. 2p.
Databáze: Academic Search Ultimate